Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Biologic License Application (BLA): 208751
Company: NOVO

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
FIASP INSULIN ASPART 1000 UNITS/10ML (100 UNITS/ML) SOLUTION;INTRAVENOUS, SUBCUTANEOUS Prescription None No No
FIASP FLEXTOUCH INSULIN ASPART 300 UNITS/3ML (100 UNITS/ML) SOLUTION;SUBCUTANEOUS Prescription None No No
FIASP PENFILL INSULIN ASPART 300 UNITS/3ML (100 UNITS/ML) SOLUTION;SUBCUTANEOUS Prescription None No No

Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
09/29/2017 ORIG-1 Approval N/A Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208751s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208751Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208751Orig1s000TOC.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
10/21/2019 SUPPL-13 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208751s008s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/208751Orig1s008, s013ltr.pdf
11/15/2019 SUPPL-12 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208751s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/208751Orig1s012ltr.pdf
12/19/2019 SUPPL-11 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208751s010s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/208751Orig1s010, s011ltr.pdf
12/19/2019 SUPPL-10 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208751s010s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/208751Orig1s010, s011ltr.pdf
10/21/2019 SUPPL-8 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208751s008s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/208751Orig1s008, s013ltr.pdf
09/04/2018 SUPPL-5 Supplement

Label is not available on this site.
09/24/2018 SUPPL-3 Supplement

Label is not available on this site.
07/22/2018 SUPPL-2 Supplement

Label is not available on this site.
03/06/2018 SUPPL-1 Supplement

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert		 Note Url
12/19/2019 SUPPL-11 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208751s010s011lbl.pdf
12/19/2019 SUPPL-10 Efficacy-New Patient Population Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208751s010s011lbl.pdf
11/15/2019 SUPPL-12 Labeling-Container/Carton Labels Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208751s012lbl.pdf
11/15/2019 SUPPL-12 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208751s012lbl.pdf
10/21/2019 SUPPL-13 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208751s008s013lbl.pdf
10/21/2019 SUPPL-8 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208751s008s013lbl.pdf
09/29/2017 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208751s000lbl.pdf

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English